Research News

Combinational therapeutic strategy for Breast Cancer treatment

Chemotherapy-associated adverse events can result in early termination of cancer treatment. In this article,  A/Prof Franco-Obregon  demonstrates the sensitivity of breast cancer cells to combinational therapy of chemotherapy and pulsed electromagnetic field therapy. The potential value of this unique combination merits future investigation into new therapeutic strategies for breast cancer treatment.

 

Read more: https://doi.org/10.3389/fonc.2021.783803

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Next-Generation Sequencing in Metastatic Breast Cancer: A Game Changer for Asian Patients

This study, led by N2CR members Dr Joline Lim and A/Prof David Tan, looks at the use of next-generation sequencing …

Read More →
Research News

Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

Cell cycle dysregulation, a key feature of cancer, leads to excessive cell division. CDK4 and CDK6 are essential for cell …

Read More →
Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. …

Read More →